Evaluation of the effect of preoperative chemotherapy in bone sarcomas. 99mTc-HMDP scintigraphy in 34 cases

Acta Orthop Scand. 1998 Dec;69(6):611-6. doi: 10.3109/17453679808999266.

Abstract

We quantitatively analyzed images of 99mTc-HMDP bone scintigraphy in 34 bone sarcomas before and after preoperative chemotherapy. The isotopic uptake was calculated as tumor-to-background ratio (TBR), and the changes in TBR before and after chemotherapy were calculated as the alteration ratio. The histological effect of preoperative chemotherapy was classified in 4 grades, according to Huvos. We defined good scintigraphic responders as cases having decreased uptake after chemotherapy, with an alteration ratio > or = 60%. There was a positive correlation (Rho = 0.76, p < 0.001) between the histological effect and the alteration ratio. Of the 17 good histological responders, 13 showed a good scintigraphic response. The average alteration ratio in 17 cases with good response (68%) was higher than that in 17 cases showing poor response (-9.9%) (p < 0.001). 3 patients with pathologic fractures and 1 with primarily normal uptake showed false negative findings. The sensitivity of this method was 100% and the specificity was 81%.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Bone Neoplasms / diagnostic imaging
  • Bone Neoplasms / drug therapy*
  • Bone Neoplasms / surgery
  • Child
  • Child, Preschool
  • Combined Modality Therapy
  • Female
  • Histiocytoma, Benign Fibrous / diagnostic imaging
  • Histiocytoma, Benign Fibrous / drug therapy
  • Histiocytoma, Benign Fibrous / surgery
  • Humans
  • Image Processing, Computer-Assisted
  • Leg / diagnostic imaging
  • Leg / surgery
  • Male
  • Neoadjuvant Therapy*
  • Osteosarcoma / diagnostic imaging
  • Osteosarcoma / drug therapy
  • Osteosarcoma / surgery
  • Radionuclide Imaging
  • Sarcoma / diagnostic imaging
  • Sarcoma / drug therapy*
  • Sarcoma / surgery
  • Sarcoma, Ewing / diagnostic imaging
  • Sarcoma, Ewing / drug therapy
  • Sarcoma, Ewing / surgery
  • Sensitivity and Specificity
  • Technetium Tc 99m Medronate / analogs & derivatives*
  • Treatment Outcome

Substances

  • technetium Tc 99m hydroxymethylene diphosphonate
  • Technetium Tc 99m Medronate